Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Scalable tobacco-cessation support for cancer survivors and their caregivers

Official title: Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Run by University of Florida · NCT06851936 · Data updated 2026-11-12

This project will try a tailored tobacco-cessation program plus provider training to help cancer survivors and their caregivers quit using tobacco.

More Tobacco Use trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment204 (estimated)
SponsorUniversity of Florida
Academic / other
Drugs / interventionsRadiation
Locations1 site (Gainesville, Florida)
StatusRecruiting
StartedJuly 11, 2025
Main results expectedJuly 2027
Study endsAugust 2027
Registry record updatedOctober 27, 2026
Trial IDNCT06851936 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult cancer survivors (including those currently in treatment) and their informal caregivers who have used any tobacco or nicotine product in the past month and receive care at participating UF Health clinics are ideal candidates.

Probably not a fit

People who have already quit, those who do not receive care at the participating UF clinics, or individuals unable to engage with the program activities may not receive benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The program combines a tailored cessation intervention for cancer survivors and their family members/caregivers who use tobacco with brief healthcare provider training in the AAC (Ask, Advise, Connect) model and C-LEAR communication skills. Patients and caregivers who report any tobacco or nicotine use in the past month and receive care in participating UF Health clinics will be enrolled. The approach is designed to integrate cessation support into oncology, urology, and radiation clinic workflows to be scalable and accessible. Outcomes will focus on engagement, quit attempts, and feasibility of broader implementation.

Why it matters

Potential benefit: If successful, the program could increase quit rates and make it easier for cancer survivors and their caregivers to get timely, tailored help to stop using tobacco.

How similar studies have gone: Prior tobacco-cessation programs and clinician training using AAC-like approaches have improved quit attempts in general populations, but scalable programs specifically tailored to cancer survivors with integrated caregiver support are relatively untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Cancer Survivors including Current Cancer Patients

* Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
* Any history of cancer diagnosis. Subjects currently receiving cancer-related treatments are eligible for enrollment.
* Receiving care from the participating UF Health clinics (Medical Oncology, Urology, and Radiation Oncology).
* Capable of completing study requirements
* Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
* Adults aged ≥18 years

Informal Caregivers/Family Members of Cancer Survivors

* Current self-reported user of any tobacco/nicotine product at time of baseline screening assessment (e.g., cigarettes, e-cigarettes, cigars, dip/chew) in the past month.
* A family member, informal caregiver, or friend of an enrolled cancer survivor receiving care from the participating UF Health clinics as described above
* Capable of completing study requirements
* Informed consent obtained from the subject and documentation of subject agreement to comply with all study-related processes
* Adults aged ≥18 years

Exclusion Criteria:

Cancer Survivors including Current Cancer Patients

* Patients unable to complete the sessions because of language, travel or technology barriers
* Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Informal Caregivers/Family Members of Cancer Survivors

* Participants unable to complete the sessions because of language, travel or technology barriers
* Prisoners or subjects who are involuntarily incarcerated, or subjects who are compulsorily detained for treatment of either a psychiatric or physical illness.

Where it's running

  • University of Florida
    Gainesville, Florida, United States
    Recruiting

Study contacts

  • Principal investigator: Jennifer LeLaurin, PhD — University of Florida
  • Study coordinator: Erika Barahona, M. Ed
  • Email: ebarahona@ufl.edu
  • Phone: 352-273-7345

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.